DE3369640D1 - Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain - Google Patents

Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain

Info

Publication number
DE3369640D1
DE3369640D1 DE8383109401T DE3369640T DE3369640D1 DE 3369640 D1 DE3369640 D1 DE 3369640D1 DE 8383109401 T DE8383109401 T DE 8383109401T DE 3369640 T DE3369640 T DE 3369640T DE 3369640 D1 DE3369640 D1 DE 3369640D1
Authority
DE
Germany
Prior art keywords
brain
improvement
treatment
pharmaceutical composition
composition useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383109401T
Other languages
German (de)
English (en)
Inventor
Shizuo Kuriyama
Mikio Saitoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Mitsubishi Chemical Industries Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3369640D1 publication Critical patent/DE3369640D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8383109401T 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain Expired DE3369640D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (1)

Publication Number Publication Date
DE3369640D1 true DE3369640D1 (en) 1987-03-12

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383109401T Expired DE3369640D1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain

Country Status (5)

Country Link
US (2) US4507322A (enExample)
EP (1) EP0103897B1 (enExample)
JP (1) JPS5955829A (enExample)
DE (1) DE3369640D1 (enExample)
IT (1) IT1169837B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 ２−（４−メチルアミノブトキシ）ジフェニルメタン・塩酸塩の製造方法
CA2153605A1 (en) * 1994-07-12 1996-01-13 Akihiro Tobe Treatment of hyperkinetic disorders
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154070C (da) * 1975-06-19 1989-02-27 Mitsubishi Chem Ind Analogifremgangsmaade til fremstilling af 2-substituerede 1-(omega-aminoalkoxy)benzenderivater
JPS606349B2 (ja) * 1975-09-10 1985-02-18 三菱化成工業株式会社 ２―（ω‐アミノアルコキシ）ジフエニルメタン類

Also Published As

Publication number Publication date
JPS5955829A (ja) 1984-03-31
JPH0233689B2 (enExample) 1990-07-30
US4507322A (en) 1985-03-26
EP0103897B1 (en) 1987-02-04
US4576966A (en) 1986-03-18
IT8322949A0 (it) 1983-09-21
EP0103897A1 (en) 1984-03-28
IT1169837B (it) 1987-06-03

Similar Documents

Publication Publication Date Title
GB2208476B (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
GB2096468B (en) Improvement in or relating to an apparatus for medical treatment
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
GR3002659T3 (en) Pharmaceutical composition for treating inflammation in the eye
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
GB9014817D0 (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
ZA763155B (en) Improvements in or relating to compounds having a physiological action on the nervous system of the human body and compositions containing them
HUT46538A (en) Process for producing pharmaceutical composition for inhibiting reduction of mental functions
PH25047A (en) Method of purifying polydextrose and composition containing them
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
DE3369640D1 (en) Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain
JPS5338631A (en) Treating composition for nerve and sympathetic nerve disease group
ZA814430B (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
DE3369296D1 (en) Device for the examination and post treatment of articles
JPS53130440A (en) Novel pharmaceutical composition having obuect to treat especially functional disorder of brain
EP0078533A3 (en) Medicinal composition for treating skin disorders
HUT44073A (en) Process for producing purified human angiogene factor and pharmaceutical compositions containing them
GR3000306T3 (en) Composition for the treatment of infections
GB2173401B (en) Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EISAI CO., LTD. MITSUBISHI KASEI CORP., TOKIO/TOKY

8339 Ceased/non-payment of the annual fee